BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25470037)

  • 1. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells.
    Rutz S; Kayagaki N; Phung QT; Eidenschenk C; Noubade R; Wang X; Lesch J; Lu R; Newton K; Huang OW; Cochran AG; Vasser M; Fauber BP; DeVoss J; Webster J; Diehl L; Modrusan Z; Kirkpatrick DS; Lill JR; Ouyang W; Dixit VM
    Nature; 2015 Feb; 518(7539):417-21. PubMed ID: 25470037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUBA-UBR5 axis: other than transactivation.
    Wu C; Chen Z; Kuchroo VK
    Cell Res; 2015 Mar; 25(3):273-4. PubMed ID: 25633593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORγt.
    Yang J; Xu P; Han L; Guo Z; Wang X; Chen Z; Nie J; Yin S; Piccioni M; Tsun A; Lv L; Ge S; Li B
    J Immunol; 2015 May; 194(9):4094-7. PubMed ID: 25821221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is DUBA putting the brake on Th17 cells?
    Brüstle A
    Immunol Cell Biol; 2015 Feb; 93(2):111-2. PubMed ID: 25559621
    [No Abstract]   [Full Text] [Related]  

  • 5. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generation of engineering Th17 cells and its function evaluation].
    Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1.
    Wang Y; Xing F; Ye S; Xiao J; Di J; Zeng S; Liu J
    Sci Rep; 2015 Feb; 5():8234. PubMed ID: 25648768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
    Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
    Su CC; Lin HC; Lin YP; Shan YS; Yang BC
    Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
    Liu HP; Cao AT; Feng T; Li Q; Zhang W; Yao S; Dann SM; Elson CO; Cong Y
    Eur J Immunol; 2015 Apr; 45(4):1010-8. PubMed ID: 25605286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deltex-1 is indispensible for the IL-6 and TGF-β treatment-triggered differentiation of Th17 cells.
    Tang Z; Wang Y; Xing R; Zeng S; Di J; Xing F
    Cell Immunol; 2020 Oct; 356():104176. PubMed ID: 32736174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway.
    Gisterå A; Robertson AK; Andersson J; Ketelhuth DF; Ovchinnikova O; Nilsson SK; Lundberg AM; Li MO; Flavell RA; Hansson GK
    Sci Transl Med; 2013 Jul; 5(196):196ra100. PubMed ID: 23903754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.
    Zhang H; Hu X; Liu X; Zhang R; Fu Q; Xu X
    Am J Reprod Immunol; 2012 Feb; 67(2):112-21. PubMed ID: 21923716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approach to generate genetically engineered, sortable, ΔNGFR-tagged mouse Th17 cells.
    Chen C; Zhang H; Han Z; Cao J; Zhang J; Chen W; Zeng L; Xu K
    Cell Biochem Biophys; 2012 Dec; 64(3):233-40. PubMed ID: 22847232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxo1 Is a T Cell-Intrinsic Inhibitor of the RORγt-Th17 Program.
    Lainé A; Martin B; Luka M; Mir L; Auffray C; Lucas B; Bismuth G; Charvet C
    J Immunol; 2015 Aug; 195(4):1791-803. PubMed ID: 26170390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bob1 enhances RORγt-mediated IL-17A expression in Th17 cells through interaction with RORγt.
    Ikegami I; Takaki H; Kamiya S; Kamekura R; Ichimiya S
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1167-1171. PubMed ID: 31103264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression.
    Wang X; Yang J; Han L; Zhao K; Wu Q; Bao L; Li Z; Lv L; Li B
    J Biol Chem; 2015 Nov; 290(48):29086-94. PubMed ID: 26453305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.